Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: a Korean Diabetes Association and Korean Society of Nephrology consensus statement

Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome trials of sodium-glucose cotransporter-2 (SGLT2) inhibitors showed profound reno-protective eff...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Kidney Res Clin Pract
Main Authors: Oh, Tae Jung, Moon, Ju-Young, Hur, Kyu Yeon, Ko, Seung Hyun, Kim, Hyun Jung, Kim, Taehee, Lee, Dong Won, Moon, Min Kyong
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Nephrology 2020
Assuntos:
Special Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7530358/
https://ncbi.nlm.nih.gov/pubmed/32938820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.23876/j.krcp.20.132
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados